Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
drugs
Sep 24, 2024, 16:25 |
Insight
Sachin Vishwasrao: Amazing to lead the participation of Reddy's Laboratories at ESMO 2024
Sachin Vishwasrao shared on LinkedIn: "It was amazing to lead the participation of Dr.Reddy's Laboratories…
Sep 24, 2024, 12:50 |
Dialogues
60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard
Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…
Sep 24, 2024, 09:07 |
Blog
We must prioritise AMR to ensure cancer treatments remain safe and effective - UICC
Union for International Cancer Control (UICC) posted on LinkedIn: "For cancer patients, antibiotics and other…
Sep 24, 2024, 02:26 |
Insight
A Dialogue with Dr. Sujuan Ba and Dr. Jemma Arakelyan During the CityU-AFCR Symposium
During the CityU-AFCR Symposium at BioHong Kong 2024 on September 12-13, Dr. Jemma Arakelyan interviewed…
Sep 23, 2024, 02:00 |
Insight
Insights on Genomics: Jemma Arakelyan Interviews Raju Kucherlapati during the CityU-AFCR Symposium
During the CityU-AFCR Symposium at BioHK 2024 on September 12-13, Dr. Jemma Arakelyan interviewed Dr.…
Sep 22, 2024, 17:37 |
Blog
Enrique Grande: Poor Outcomes for Basal/Squamous and Mixed Bladder Cancers in the VESPER Trial
Enrique Grande shared the following on LinkedIn: “Basal/squamous and Mixed subtype bladder cancers present poor…
Sep 22, 2024, 16:47 |
Insight
Samuel Hume: Biggest medical discoveries of the week
Samuel Hume, Scientist at University of Oxford, shared a post on X: "Biggest medical discoveries…
Sep 22, 2024, 15:24 |
Opinion
CancerX Moonshot and the Role of Digital Patient Navigation in Reducing Financial Toxicity
The Need for Patient Navigation and the CancerX Moonshot Patients with cancer and their families…
Sep 22, 2024, 14:45 |
Blog
Amol Akhade: ADC In NSCLC
Amol Akhade shared a post on LinkedIn: "ADC In NSCLC. All Drugs in One Slide .…
Sep 22, 2024, 12:38 |
Blog
Amol Akhade: Cabozantinib plus Atezolizumab vs second-line NHT in prostate cancer
Amol Akhade shared a post on LinkedIn: ''Cabozantinib plus Atezolizumab versus second-line Non-hormonal Therapy (NHT)…
9
10
11
12
13
All:
828
Posts:
101 - 110
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube